With unprecedented interest in the power that the modern therapeutic armamentarium has to combat disease, the new edition of Drug Discovery and Development is an essential resource for anyone interested in understanding how drugs and other therapeutic interventions are discovered and developed, through to clinical research, registration, and market access.
The text has been thoroughly updated, with new information on biopharmaceuticals and vaccines as well as clinical development and target identification. Drug discovery and development continues to evolve rapidly and this new edition reflects important changes in the landscape.
Edited by industry experts Raymond Hill and Duncan Richards, this market-leading text is suitable for undergraduates and graduates undertaking degrees in pharmacy, pharmacology, toxicology, and clinical development through to those embarking on a career in the pharmaceutical industry.
Key Features
| ISBN | 9780702078057 |
|---|---|
| Product Format | Ebook |
| Publication Date | 2021 |
| Author Information | By Raymond G Hill, President, British Pharmacological Society, London, UK and Duncan Richards, Professor Duncan Richards MA DM FRCP FFPM FBPharmacolS, St Hilda's College,Oxford |
| Table of Content | Section 1 Introduction and Background 1. Development of the pharmaceutical industry 2. Nature of disease and purpose of therapy 3. Therapeutic modalities Section 2 Drug Discovery 4. Drug target identification 5. Selecting the modality and planning the project 6. High throughput screening 7. Medicinal Chemistry 8. Biopharmaceuticals and related molecules 9. Emerging modalities: nucleotide based therapy, cell based therapy, gene therapy / Novel and Advanced Process 10. Metabolism and Pharmacokinetical strategies. 11. Role of pharmacology to include pharmacology of newer modalities 12. In vitro in vivo translation 13. Vaccines Section 3 Drug Development 14. Drug development introduction 15. Drug safety 16. Pharmaceutical development 17. Clinical development 18. Clinical imaging 19. Intellectual property 20. Regulatory affairs 21. Marketing and Patient access to medicines Section 4 Facts and Figures 22. Facts and Figures; and the Future |
| Publication Date | 16-05-2021 |
| Pages | 374 |
| Trim | 235 x 191 (7 1/2 x 9 1/4) |
| deltacomm1code | Electronic Book |
